Motility News

PHILADELPHIA — In this exclusive video perspective from the American College of Gastroenterology Annual Meeting, Nicholas Talley, MD, PhD, FACG, from the University of Newcastle in Australia, discusses the changing world of functional gastrointestinal disorders.

PHILADELPHIA — According to research presented at the American College of Gastroenterology Annual Meeting, biofeedback therapy administered with a home-based device was as good as, if not better than, biofeedback administered in an office setting.

PHILADELPHIA — An orally administered, intraluminal capsule appeared effective for the treatment of chronic idiopathic constipation, according to research presented at the American College of Gastroenterology Annual Meeting.

By a 10-0 vote, the FDA Gastrointestinal Drugs Advisory Committee voted to approve prucalopride for chronic idiopathic constipation, according to a press release from Shire, its manufacturer.

The International Foundation for Gastrointestinal Disorders announced that the online nomination period has begun for the 2019 Research Recognition Awards.

A multidisciplinary treatment approach that combined gastrointestinal, pain and psychologic factors helped improve symptoms in children with functional gastrointestinal disorders, according to research published in Clinical Gastroenterology and Hepatology.

WASHINGTON — Implementing a patient-specific action plan helped reduce unnecessary referrals to pediatric gastroenterologists among children with constipation, according to research presented at Digestive Disease Week.

WASHINGTON — Results from an ongoing study on endoscopic anterior fundoplication for the treatment of GERD showed significant reduction in proton-pump inhibitor use and reflux periods, according to research presented at Digestive Disease Week 2018.

Gastroesophageal reflux, a common and normal condition among preterm neonates, should be diagnosed using signs of the condition such as feeding intolerance and irritability, and treated without the use of pharmacologic agents, according to a clinical report issued by the AAP Committee on Fetus and Newborn.

WASHINGTON — Patients who undergo Roux-en-Y-gastric bypass have lower odds of developing GERD and esophagitis after they undergo surgery, compared with other gastric bypass surgery types, according to data presented at Digestive Disease week.